Welcome to 2022 Stanford Drug Discovery Symposium. This symposium provides a valuable and important platform for inspiring interdisciplinary exchange at the forefront of drug research and will support a fantastic networking experience. It provides a great resource for researchers, pharmaceutical companies, investment groups, and those in the wider biomedical community interested in discovering new drugs and improving patient care. We look forward to an exciting two days of talks and discussion.

Joseph C. Wu, MD, PhD | Director, Cardiovascular Institute

Lifetime Achievement Awardee

Katalin Karikó, PhD

Senior VP, BioNTech

Participants

Karen Akinsanya, PhD

President of R&D, Therapeutics
Schrödinger

James (Jay) Bradner, MD

President
Novartis Institutes for BioMedical Research

Hogene L. Choi, JD

Partner
Morrison & Foerster, LLP

Myrtle Davis, DVM, PhD

Scientific Vice President, Discovery Toxicology
Bristol Myers Squibb

Kathy Giacomini, PhD

Prof of Bioengineering & Co-Dir UCSF-Stanford Center of Excellence in Regulatory Sciences and Innovation, UCSF

David Goel

Founder & Managing General Partner, Matrix Capital Management

Karin Immergluck, PhD

Executive Director
Stanford Office of Technology Licensing (OTL)

Daphne Koller, PhD

Founder & Chief Executive Officer
Insitro

Mathai Mammen, MD, PhD

Executive Vice President, Pharmaceuticals, R&D
Johnson & Johnson

Maria Millan, MD

President and Chief Executive Officer, CIRM

Merdad Parsey, MD, PhD

Chief Medical Officer, Gilead

Madhuri Roy, PhD, JD

Partner, Patent Counseling & Prosecution
Cooley

Marc Tessier-Lavigne, PhD

President and Bing Presidential Professor
Stanford University

Steve Artandi, MD, PhD

Laurie Kraus Lacob Director (SCI); Jerome and Daisy Low Gilbert Professor (Med and Biochem), Stanford 

Amy L. Chang

Board of Directors at The Walt Disney Co, Procter & Gamble, Marqeta, and Pragma Platform 

Jacqueline Corrigan-Curay, JD, MD

Principal Deputy Center Director
FDA, CDER

Ray Deshaies, PhD

Senior Vice President, Global Research
Amgen

Gary Gibbons, MD

Director, NHLBI

Aida Habtezion, MD

Chief Medical Officer and Head of Worldwide Medical & Safety
Pfizer

Joe Jimenez, MBA

Co-Founder and Managing Director
Aditum Bio

Dean Li, MD, PhD

Executive Vice President and President of Merck Research Laboratories

Peter Marks, MD, PhD

Director, Center for Biologics Evaluation and Research
U.S. Food and Drug Administration

Lloyd Minor, MD

Carl and Elizabeth Naumann Professorship for the Dean, Stanford School of Medicine

Andrew Plump, MD, PhD

President, Research & Development
Takeda Pharmaceutical Company Limited

Alfred Sandrock, MD, PhD

CEO
Voyager Therapeutics

James Zou, PhD

Assistant Professor of Biomedical Data Science and, by courtesy, of CS and of EE
Stanford University

Claude Bertrand, PhD

Executive Vice President, Chief Scientific Officer, R&D
Servier

Margarita Chavez, JD

Managing Director
AbbVie Ventures

Lisa Coussens, PhD

Associate Director for Basic Research, Knight Cancer Institute, OHSU; and President, AACR

Carlos O. Garner, PhD

Vice President, Global Regulatory Affairs
Eli Lilly and Company

Christopher Gibson, PhD

Co-Founder, Chief Executive Officer of Recursion

Sandra J. Horning, MD

Board of Directors: Gilead, Moderna, & Olema Pharma.
Co-founder & Advisor, EQRx

Peter S. Kim, PhD

Virginia and D.K. Ludwig Professor of Biochemistry
Stanford University

Jonathan MacQuitty, PhD

Sector Head for Life Sciences
Lightspeed Ventures

Michelle McMurry-Heath, MD, PhD

President & CEO, Biotechnology Innovation Organization

Vern Norviel, JD

Partner, Patents and Innovations
Wilson Sonsini

Aviv Regev, PhD

Executive Vice President, Research and Early Development
Genentech

Randy Schekman, PhD

Professor of Molecular and Cell Biology, University of California, Berkeley; 2013 Nobel Laureate

Agenda

Organizers

Amanda Chase, PhD

Associate Director of Strategic Research Development
Stanford Cardiovascular Institute

Kuldev Singh, MD

Professor of Ophthalmology
Stanford University School of Medicine

Sanjay Malhotra, PhD

Professor, Cell, Developmental & Cancer Biology; Director, Center for Experimental Therapeutics
OHSU

Joseph Wu, MD, PhD

Director, Stanford CVI
Simon H. Stertzer, MD, Professor, Department of Medicine and Radiology
Stanford University School of Medicine

Mark Mercola, PhD

Professor of Medicine
Stanford University School of Medicine

Platinum Sponsors

Gold Sponsors

Silver Sponsors

Media Sponsors

listed alphabetically


For additional information, please contact Joseph C. Wu, MD, PhD, or Francesca Tongco.